Your browser is no longer supported. Please, upgrade your browser.
PFE Pfizer Inc. daily Stock Chart
Pfizer Inc.
IndexDJIA S&P500 P/E23.25 EPS (ttm)1.81 Insider Own0.10% Shs Outstand5.58B Perf Week2.04%
Market Cap234.42B Forward P/E13.91 EPS next Y3.02 Insider Trans-13.69% Shs Float5.56B Perf Month6.52%
Income10.67B PEG4.86 EPS next Q0.74 Inst Own74.90% Short Float0.86% Perf Quarter-0.36%
Sales53.86B P/S4.35 EPS this Y-11.90% Inst Trans-2.17% Short Ratio2.03 Perf Half Y-3.49%
Book/sh10.43 P/B4.03 EPS next Y4.50% ROA7.10% Target Price45.00 Perf Year17.29%
Cash/sh2.08 P/C20.18 EPS next 5Y4.79% ROE17.40% 52W Range35.32 - 46.47 Perf YTD-3.80%
Dividend1.44 P/FCF43.14 EPS past 5Y1.00% ROI10.20% 52W High-9.64% Beta0.69
Dividend %3.43% Quick Ratio1.30 Sales past 5Y0.80% Gross Margin79.60% 52W Low18.88% ATR0.72
Employees92400 Current Ratio1.50 Sales Q/Q1.60% Oper. Margin23.30% RSI (14)61.03 Volatility1.36% 1.61%
OptionableYes Debt/Eq0.77 EPS Q/Q14.90% Profit Margin21.30% Rel Volume1.02 Prev Close41.67
ShortableYes LT Debt/Eq0.61 EarningsApr 30 BMO Payout69.60% Avg Volume23.47M Price41.99
Recom2.50 SMA202.93% SMA501.34% SMA200-1.23% Volume23,979,958 Change0.77%
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Jan-31-19Upgrade Argus Hold → Buy
Jan-23-19Downgrade UBS Buy → Neutral
Dec-11-18Downgrade JP Morgan Overweight → Neutral
Nov-01-18Downgrade BMO Capital Markets Outperform → Market Perform
Jun-08-18Initiated Cantor Fitzgerald Overweight $45
Apr-05-18Downgrade Barclays Overweight → Equal Weight $41 → $38
Jan-29-18Reiterated SunTrust Hold $33 → $40
Sep-20-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-20-17Downgrade Credit Suisse Outperform → Neutral
May-16-17Downgrade Citigroup Neutral → Sell
Dec-02-16Initiated Guggenheim Neutral
Nov-02-16Downgrade Argus Buy → Hold
Oct-13-16Downgrade Jefferies Buy → Hold
Jun-20-16Reiterated Jefferies Buy $42 → $40
May-12-16Initiated Berenberg Hold $38
May-04-16Reiterated UBS Buy $36 → $38
Apr-18-16Resumed Goldman Neutral $35
Apr-07-16Resumed Morgan Stanley Equal-Weight $35
May-21-19 05:36PM  Ocular's Glaucoma Drug Study Fails to Meet Primary Endpoint Zacks
01:01PM  Stocks To Buy: Is It Time To Buy Or Sell These Large-Cap Stocks? Investor's Business Daily
09:00AM  Better Buy: AbbVie vs. Pfizer Motley Fool
08:46AM  Merck's Keytruda Fails in Late-Stage Breast Cancer Study Zacks
May-20-19 02:44PM  Primary Drivers of the Chinese Economy Investopedia
12:04PM  Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock InvestorPlace
May-19-19 09:00AM  Better Buy: Eli Lilly vs. Pfizer Motley Fool
May-18-19 06:30AM  Where Will Pfizer Be in 5 Years? Motley Fool
May-17-19 08:35AM  Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs Zacks
08:24AM  Dow 30 Stock Roundup: Walmart, Cisco Earnings Impress Zacks
May-16-19 09:40AM  Pfizer Gains After Being Named 'Top Pick' by Credit Suisse
08:20AM  Pfizer's Eczema Candidate Meets All Goals in Phase III Study Zacks
08:08AM  Here are the biggest analyst calls of the day: Macy's, Pfizer, Owens Corning & more CNBC
08:06AM  Stocks making the biggest moves premarket: Walmart, Pfizer, PG&E, Sony, Tesla & more CNBC
08:00AM  Generic Drugs Are Stabilizing Can They Survive An Antitrust Scandal? Investor's Business Daily
May-15-19 05:01PM  Pfizer Oncology to Showcase New Data from Innovative Science That Address Patient Needs at ASCO 2019 Annual Meeting Business Wire
04:38PM  This Dow Jones Pharma Giant Is Now A 'Top Pick' Here's Why Investor's Business Daily
02:16PM  Pfizer Stock Is The Biggest Pharma But Should You Buy It? Investor's Business Daily
11:47AM  Teva Hits Fibonacci Support on Concerns Over Lawsuit Investopedia
09:27AM  Pfizer's Bavencio+Inlyta Combo Gets FDA Nod for Kidney Cancer Zacks
09:24AM  The Zacks Analyst Blog Highlights: Teva, Mylan, Novartis and Pfizer Zacks
07:50AM  The Daily Biotech Pulse: FDA Greenlights Pfizer-Merck KGAa's Kidney Cancer Combo Treatment, Adcom Disappointment For Daiichi Benzinga
07:46AM  AbbVie Settles Humira Litigation With Boehringer Ingelheim Zacks
07:12AM  Pfizer's atopic dermatitis treatment meets goals in late-stage study Reuters
07:00AM  Matinas BioPharma Announces a Research Collaboration with ViiV Healthcare to Evaluate Formulation of Antiviral Drug Candidates GlobeNewswire
06:55AM  Pfizer's dermatitis treatment meets main goals of late-stage study Reuters
06:45AM  Pfizer Announces Positive Top-Line Results from Phase 3 Study of Investigational Oral JAK1 Candidate, Abrocitinib (PF-04965842), in Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis Business Wire
May-14-19 08:25PM  FDA Approves BAVENCIO® (avelumab) plus Axitinib Combination for Patients with Advanced Renal Cell Carcinoma PR Newswire
07:44PM  FDA Approves BAVENCIO® (avelumab) Plus INLYTA® (axitinib) Combination for Patients with Advanced Renal Cell Carcinoma PR Newswire
09:18AM  Generic Drugmakers Face Antitrust Suit Alleging Price Fixing Zacks
May-13-19 09:04AM  TV networks emerge as obstacles on YouTube's hunt for ads Reuters
08:40AM  Teva Plummets Amid Massive Price Fixing Accusations; Other Generic Drugmakers Also Fall Benzinga
06:13AM  TV networks emerge as obstacles on YouTube's hunt for ads Reuters
06:00AM  FOCUS-TV networks emerge as obstacles on YouTube's hunt for ads Reuters
May-12-19 11:00PM  US generic drug companies hit by price-fixing claims Financial Times
11:00AM  Top vaccine makers Merck and Pfizer target China and older adults next CNBC
10:02AM  The money behind vaccines CNBC Videos
May-11-19 10:30AM  How Viagra revolutionized the erectile dysfunction market CNBC
08:02AM  What happened to Viagra after Pfizer's patent for the 'wonder pill' expired CNBC Videos
May-10-19 11:38AM  National Mutual Insurance Federation of Agricultur Buys Pfizer Inc, PayPal Holdings Inc, Sells ...
07:34AM  Pharma Stock Roundup: AGN, NVO Report Q1 Earnings, NVS to Buy Takeda's Eye Drug Zacks
06:00AM  Buckingham's Bets- Two Values in Healthcare MoneyShow
May-09-19 10:54PM  ICU Medical, Inc. (ICUI) Q1 2019 Earnings Call Transcript Motley Fool
09:00AM  Why Exact Sciences Shrugged Off the Moody Market in April Motley Fool
May-08-19 10:15PM  What You Need to Know About Sangamo Therapeutics' Q1 Earnings Results Motley Fool
09:37PM  GSK-Pfizer deal gets approval from Australia's anti-trust watchdog Reuters
09:02PM  Australia's anti-trust watchdog gives go-ahead for GSK-Pfizer consumer healthcare deal Reuters
02:45PM  Aerie (AERI) Q1 Earnings Beat, Rhopressa Misses Estimates Zacks
11:17AM  Pfizer Buys Rare Disease Biotech Therachon For $340M Benzinga
10:38AM  Drug/Biotech Stock Q1 Earnings on May 9: IONS, XLRN & More Zacks
09:56AM  Array BioPharma (ARRY) Q3 Earnings and Sales Beat Estimates Zacks
06:45AM  Pfizer Acquires Clinical-Stage Biotech Therachon Business Wire
May-07-19 08:21PM  Can Pfizer Leap Over the Competition With This Potential Blockbuster? Motley Fool
09:35AM  What's in the Cards for Nektar (NKTR) This Earnings Season? Zacks
07:00AM  European Commission Approves LORVIQUA® (lorlatinib) for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer Business Wire
May-06-19 04:14PM  How Dow Jones' Pfizer Could Take On New Drugs From 2 Biotech Stocks Investor's Business Daily
02:53PM  Conatus' (CNAT) Earnings, Revenues Miss Estimates in Q1 Zacks
12:41PM  Pfizer Gets FDA Approval for $225,000 Heart Disease Drug
12:12PM  7 Stocks to Buy From the T. Rowe Price Health Sciences Fund InvestorPlace
10:43AM  Here are the biggest stock-market losers after Trump threatens more tariffs MarketWatch
10:33AM  Pfizer gets U.S. approval for $225,000 a year heart drug Reuters
10:22AM  Pfizer gets U.S. approval for $225,000 a year heart drug Reuters
09:21AM  The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo Zacks
09:08AM  The Zacks Analyst Blog Highlights: Pfizer, Intel, HCA Healthcare, Xilinx and Cummins Zacks
06:51AM  Pfizer gets U.S. approval for $225,000 a year heart drug Reuters
06:45AM  U.S. FDA Approves VYNDAQEL® and VYNDAMAX for Use in Patients with Transthyretin Amyloid Cardiomyopathy, a Rare and Fatal Disease Business Wire
May-05-19 07:30AM  5 Reasons Why Pfizer Is a Great Stock to Buy and Hold for the Long Term Motley Fool
May-04-19 04:23PM  GlycoMimetics (GLYC) Q1 2019 Earnings Call Transcript Motley Fool
May-03-19 03:43PM  Top Stock Reports for Pfizer, Intel & HCA Healthcare Zacks
09:46AM  Drugmakers lobbying spending at 10-year high as Washington targets soaring prices MarketWatch
06:10AM  Pharma Stock Roundup: MRK, LLY, PFE Report Q1 Earnings, SNY, ABBV Drugs Get EU Nod Zacks
05:13AM  Dow 30 Stock Roundup: AAPL, PFE, MRK, MCD Earnings Impress Zacks
May-02-19 02:18PM  Pfizer Stock Rebounds Under Cloud of Negative Charts Investopedia
11:21AM  Exelixis (EXEL) Earnings & Revenues Beat Estimates in Q1 Zacks
09:16AM  Glaxo (GSK) Beats on Q1 Earnings & Sales, Shingrix Impresses Zacks
05:20AM  These 6 biotech stocks are promising takeover targets MarketWatch
May-01-19 06:56PM  The Top Pharma Stocks for 2019 Investopedia
06:00PM  The top 2 health care names to play for a catch-up: Technician CNBC Videos
02:00PM  9 Hot Stocks to Buy Now InvestorPlace
09:05AM  Amgen (AMGN) Q1 Earnings Top, Sales Hurt by Pricing Pressure Zacks
Apr-30-19 09:25PM  Pfizer Inc (PFE) Q1 2019 Earnings Call Transcript Motley Fool
09:06PM  Edited Transcript of PFE earnings conference call or presentation 30-Apr-19 2:00pm GMT Thomson Reuters StreetEvents
07:36PM  Alphabet Throws a Wet Blanket on Wall Street Investopedia
06:25PM  US STOCKS-S&P 500 posts best four-month run in nearly 9 years; Apple jumps after hours Reuters
04:57PM  US STOCKS-Nasdaq retreats as Alphabet falls but Apple gains after hours Reuters
04:22PM  S&P 500 ekes out third straight record close; Nasdaq retreats after Google revenue miss MarketWatch
04:11PM  Dow Drug Giants Top First-Quarter Estimates; But Another Pharma Dives Investor's Business Daily
03:27PM  Pfizer 1Q profit jumps 9% on higher drug sales, lower costs Associated Press
03:18PM  Trump, Democratic leaders to meet on drug prices soon -White House Reuters
03:14PM  US STOCKS-Wall St's recent rally stumbles as Alphabet falls Reuters
02:48PM  McDonald's earnings sizzle on its bacon promotions, Alphabet's big miss, Netflix's ad destiny and Pfizer's drug pricing pressure CNBC Videos
01:28PM  US STOCKS-Wall Street's record run hits snag after Alphabet tumbles Reuters
01:14PM  Pfizer CEO: Drug prices will not be a growth driver CNBC Videos
01:00PM  Vaccine and blood thinner help drive Pfizer to quarterly earnings beat Reuters
01:00PM  What You Need to Know About Pfizer's Q1 Earnings Beat Motley Fool
12:42PM  Stocks making the biggest moves midday: Alphabet, GE, McDonald's,Texas Roadhouse & more CNBC
11:51AM  Pfizer Lifts 2019 Earnings Forecast as Biopharma Sales Drive Q1 Profit Beat
10:46AM  Big Pharma Puts the Price Squeeze on Itself Bloomberg
10:30AM  US STOCKS-Wall Street pauses after record run as Alphabet tumbles Reuters
10:21AM  Q1 Earnings Continue Zacks
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands. The company also provides consumer healthcare products that comprise over-the-counter medicines, including dietary supplement products under the Centrum, Caltrate, and Emergen-C names; pain management products under the Advil and ThermaCare names; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H names; and respiratory and personal care products under the Robitussin, Advil Cold & Sinus, and ChapStick names. In addition, it offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit, Ixifi Infliximab BS names. Further, the company is also involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Merck KGaA; licensing agreement with BionTech AG; and collaboration agreements with Merck & Co., Inc. and Eli Lilly & Company, as well as with Merck KGaA and Nektar Therapeutics to develop a therapy for treating pancreatic cancer. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PFIZER INC10% OwnerMay 13Buy17.0050,000850,0003,249,973May 14 07:34 AM
MACKENZIE ALEXANDER RExecutive Vice PresidentApr 01Sale42.8315,000642,503110,094Apr 02 03:05 PM
JOHNSON RADY AExecutive Vice PresidentMar 15Sale41.138,700357,83159,797Mar 18 06:37 PM
READ IAN CExecutive ChairmanMar 04Sale43.2950,7882,198,4741,639,280Mar 06 04:03 PM
READ IAN CExecutive ChairmanMar 04Sale43.17530,07822,882,7021,109,202Mar 06 04:03 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale43.268,725377,444172,094Mar 06 03:29 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale43.1463,9982,760,698108,096Mar 06 03:29 PM
Dolsten MikaelPresident R&DMar 04Sale43.5249,0822,136,293289,126Mar 05 04:54 PM
ROGERS DAWNExecutive Vice PresidentMar 04Sale42.9815,002644,79814,920Mar 05 04:55 PM
Dolsten MikaelPresident R&DMar 01Option Exercise31.34106,1913,328,057438,679Mar 05 04:54 PM
Dolsten MikaelPresident R&DMar 01Sale43.56100,4714,376,852338,208Mar 05 04:54 PM
ROGERS DAWNExecutive Vice PresidentFeb 27Option Exercise32.2319,297621,94245,049Mar 01 07:47 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Option Exercise32.2385,7632,764,141228,743Mar 01 07:47 PM
YOUNG JOHN DGroup PresidentFeb 27Option Exercise32.23154,3744,975,474441,923Mar 01 07:47 PM
GOETTLER MICHAELGroup PresidentFeb 27Option Exercise32.2330,017967,44848,652Mar 01 07:37 PM
Hwang AngelaGroup PresidentFeb 27Option Exercise32.2311,792380,05623,635Mar 01 07:37 PM
JOHNSON RADY AExecutive Vice PresidentFeb 27Option Exercise32.2330,017967,44881,341Mar 01 07:37 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27Option Exercise32.2364,3222,073,098123,145Mar 01 07:37 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 27Option Exercise32.2381,4752,625,939416,278Mar 01 07:37 PM
BOURLA ALBERTChief Executive OfficerFeb 27Option Exercise32.2364,3222,073,098331,982Mar 01 07:29 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 27Option Exercise32.2325,729829,246121,743Mar 01 07:29 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 27Option Exercise32.23182,2475,873,821588,177Mar 01 07:29 PM
YOUNG JOHN DGroup PresidentFeb 23Option Exercise21.0343,724919,516312,403Feb 26 07:45 PM
JOHNSON RADY AExecutive Vice PresidentFeb 23Option Exercise21.0318,004378,62461,182Feb 26 07:45 PM
BOURLA ALBERTChief Executive OfficerFeb 23Option Exercise21.0336,008757,248191,438Feb 26 07:45 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 23Option Exercise21.0387,4491,839,052388,024Feb 26 07:45 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 23Option Exercise21.03185,1853,894,441522,576Feb 26 07:45 PM
SUSMAN SALLYExecutive Vice PresidentFeb 23Option Exercise21.0397,7372,055,409205,833Feb 26 07:46 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 23Option Exercise21.0343,724919,51683,781Feb 26 07:45 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 23Option Exercise21.0341,615875,163144,164Feb 26 07:10 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 23Option Exercise21.0330,864649,070115,139Feb 26 07:10 PM
ROGERS DAWNExecutive Vice PresidentFeb 23Option Exercise21.0319,290405,66937,638Feb 26 07:10 PM
GOETTLER MICHAELGroup PresidentFeb 23Option Exercise21.0319,290405,66931,507Feb 26 07:11 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 01Sale42.755,000213,75040,057Feb 01 07:21 PM
Dolsten MikaelPresident R&DJan 31Option Exercise29.78125,9683,751,425362,051Feb 01 07:28 PM
LANKLER DOUGLAS MExecutive Vice PresidentJan 30Sale41.1938,8001,598,07145,057Feb 01 07:21 PM
READ IAN CChairman & CEONov 02Option Exercise26.641,100,20129,312,5881,760,958Nov 06 03:46 PM
PFIZER INC10% OwnerOct 15Buy18.0055,5561,000,00822,032,040Oct 17 05:17 PM
Dolsten MikaelPresident R&DSep 13Option Exercise24.56181,7124,462,167234,299Sep 17 04:08 PM
OLSON LAURIE JExecutive Vice PresidentAug 13Sale41.0010,214418,77472,672Aug 14 05:04 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentAug 03Sale39.5125,6421,013,171102,412Aug 06 03:19 PM
GOETTLER MICHAELGroup PresidentAug 01Sale39.7019,198762,11611,924Aug 03 03:38 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerAug 01Sale40.1626,8141,076,93383,846Aug 03 03:36 PM
LUND-JURGENSEN KIRSTENExecutive Vice PresidentAug 01Sale40.0420,942838,5724,643Aug 03 03:35 PM
DAMELIO FRANK AExecutive Vice PresidentAug 01Sale40.00150,4846,019,360337,391Aug 03 03:33 PM
SUSMAN SALLYExecutive Vice PresidentJul 20Sale37.2240,3811,502,925115,096Jul 24 01:09 PM
READ IAN CChairman & CEOJul 16Sale37.36486,75318,186,315659,440Jul 17 04:59 PM
OLSON LAURIE JExecutive Vice PresidentJun 06Sale36.4519,000692,58282,886Jun 08 01:11 PM
CORNWELL W DONDirectorJun 04Sale36.405,223190,1170Jun 05 04:44 PM